Cancer is a complex disease that can develop when changes in our DNA disrupt normal cell growth and repair. These genetic changes may be inherited or acquired over time, and understanding them is key to early detection, accurate diagnosis, and effective treatment. With next-generation sequencing (NGS) technology, it's now possible to analyze both inherited and tumor-specific mutations to gain deep insights into cancer risk, tumor behavior, and potential treatment response.
ATENA Genomics offers a range of advanced NGS-based cancer testing services — including hereditary cancer screening, tumor profiling, liquid biopsies, and drug resistance monitoring. Each test is designed to support personalized cancer care by providing actionable genetic information that can guide prevention, treatment decisions, and ongoing management.
Comprehensive genomic analysis of tumor tissue to identify key mutations.
Non-invasive cancer detection and monitoring from blood samples.
Identification of inherited genetic risk factors for various cancers.
Non-invasive cancer detection and monitoring from blood samples.